Taken together, we show that Alb-IFNβ is able to enhance TA-CIN-elicited antitumor effects to suppress tumor growth and we believe that Alb-IFNβ serves as a potentially potent immunologic adjuvant. The gene discussed is ALB; the disease is neoplasm.